Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marco Colleoni

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Journal of Clinical Oncology

English

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor–Positive, HER2-Negative Early Breast Cancer

English

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Predictors of Prolonged Benefit From Palbociclib Plus Fulvestrant in Women With Endocrine-Resistant Hormone Receptor–positive/Human Epidermal Growth Factor Receptor 2–negative Metastatic Breast Cancer in PALOMA-3

European Journal of Cancer

Cancer Research

Oncology

2018

English

Endocrine-Responsive Lobular Carcinoma of the Breast: Features Associated With Risk of Late Distant Recurrence

Breast Cancer Research

Cancer Research

Oncology

2019

English

Quality of Life Under Extended Continuous Versus Intermittent Adjuvant Letrozole in Lymph Node-Positive, Early Breast Cancer Patients: The SOLE Randomised Phase 3 Trial

British Journal of Cancer

Cancer Research

Oncology

2019

English

Outcomes of Patients With Breast Cancer Who Present With Ipsilateral Supraclavicular or Internal Mammary Lymph Node Metastases

Clinical Breast Cancer

Cancer Research

Oncology

2014

English

Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome

Clinical Breast Cancer

Cancer Research

Oncology

2013

English

Invasive Ductal Carcinoma of the Breast With the “Triple-Negative” Phenotype: Prognostic Implications of EGFR Immunoreactivity

Breast Cancer Research and Treatment

Cancer Research

Oncology

2008

English

Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marco Colleoni

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor–Positive, HER2-Negative Early Breast Cancer

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Predictors of Prolonged Benefit From Palbociclib Plus Fulvestrant in Women With Endocrine-Resistant Hormone Receptor–positive/Human Epidermal Growth Factor Receptor 2–negative Metastatic Breast Cancer in PALOMA-3

Endocrine-Responsive Lobular Carcinoma of the Breast: Features Associated With Risk of Late Distant Recurrence

Quality of Life Under Extended Continuous Versus Intermittent Adjuvant Letrozole in Lymph Node-Positive, Early Breast Cancer Patients: The SOLE Randomised Phase 3 Trial

Outcomes of Patients With Breast Cancer Who Present With Ipsilateral Supraclavicular or Internal Mammary Lymph Node Metastases

Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome

Invasive Ductal Carcinoma of the Breast With the “Triple-Negative” Phenotype: Prognostic Implications of EGFR Immunoreactivity

Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer